Clinical trial
Assessment the Safety and Efficacy of Debulking Atherectomy Versus Stent Angioplasty for Limb Ischaemia of Diabetic Lower Limb Atherosclerosis-occlusive Disease: A Multicenter, Randomized, Controlled Study.
NCT05670171 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment the Safety and Efficacy of Debulking Atherectomy Versus Stent Angioplasty for Limb Ischaemia of Diabetic Lower Limb Atherosclerosis-occlusive Disease: A Multicenter, Randomized, Controlled Study.
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2023
- Completion date
- December 31, 2025
- Enrollment
- 244 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.